🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This biotech startup thinks it can delay menopause by 15 years. That would transform women’s lives bit.ly/32stP2T

The menopause moonshot has been unlocked! So proud Piraye Yurttas Beim, PhD fortune.com/2021/04/19/cel…

Super proud to be coming out of stealth on our Celmatix drug program aimed at delaying menopause. fortune.com/2021/04/19/cel…

Linda Griffith is on a mission to change the conversation around endometriosis, a chronic disorder often dismissed as a “women’s disease.” The MIT professor’s research on the uterus could offer a window into some of biology’s greatest secrets. nyti.ms/3dUozvz

Thankful for brave innovators like Prof Linda Gay Griffith. nytimes.com/2021/04/27/hea…

Reading some responses to interview q's from Piraye Yurttas Beim, PhD for my newsletter and I'm digging her suggestion of a Softbank Vision Fund dedicated to women's health. As she puts it: "It’s going to take investors with deep conviction and deep pockets to really transform this field."

#PCOS is often dismissed as a #womenshealth issue, meaning that "Over the past year, we've learned about numerous preexisting health conditions that put a person at higher risk for severe Covid-19 illness, but PCOS isn't one of them." - cnn.com/2021/05/23/hea…

"As a 30 year veteran of therapeutic discovery and development in women’s health, I know there are less-than-ideal solutions to treat conditions that affect women." Celmatix #biotech #womenshealth femtechinsider.com/stephen-palmer…

"Women’s health is so much bigger than periods and pregnancy" - Christina Farr Piraye Yurttas Beim, PhD Deena Shakir and Lily Shaw weigh in on the opportunity in women's health.

"As someone who has been innovating in women’s health for over 20 years, I can tell you that there has been a sea change over the last 18 months in the attitude and desire to fund women’s health."Piraye Yurttas Beim, PhD CEO and Founder of Celmatix bit.ly/3vJ7evV

Dr. Roberta Brinton (Roberta Brinton), Director of Center for Innovation in Brain Science, is a champion for women-focused #Alzheimers research. We need to increase funding for #SABV research, so she and other researchers can advance their groundbreaking work. #AlzheimersAwarenessMonth sciencetimes.com/articles/31136…

Huge congratulations to a team that always takes the hard road rather than the “wellness” road. Another great FDA milestone for Natural Cycles° .

Today, FDA approved the first COVID-19 vaccine for the prevention of #COVID19 disease in individuals 16 years of age and older. fda.gov/news-events/pr…

Weaving together the demands of advanced clinical trials with expanding options for business development, the importance of “tough but fair.” Plus a great guest speaker— Piraye Yurttas Beim, PhD, CEO of Celmatix. Tomorrow in #Entrepreneurship in #Biotechnology Columbia University

Such a fun time reliving the early days of Celmatix with David’s class today. David Sable

Validation of our 1st #pcos #drugdiscovery program by our partners at Evotec and Bayer AG #womenshealth bwnews.pr/3fBozAE

"We are confident that the proprietary data in our in-silico discovery platform, paired with our deep expertise in female biology, will unlock novel biological insights & drive innovation in #womenshealth therapeutic development." Piraye Yurttas Beim, PhD Celmatix femtechinsider.com/celmatix-evote…

@DDNewsOnline's Natalya Ortolano interviews our CEO Dr. Piraye Yurttas Beim, PhD in headlining article "Is Anti-Müllerian Hormone the New Estrogen?" bit.ly/34jKs5z #WomensHealth #biotech

“AMH and its receptor are really the missing hormonal pathway in the pantheon of key reproductive pathways regulating the ovaries. We are seeing it emerge as a very exciting therapeutic target,” Piraye Yurttas Beim, PhD from Celmatix told me in my latest story. drugdiscoverynews.com/anti-mllerian-…

Forbes' @MarijaButkovic interviews our CEO Dr. Piraye Yurttas Beim, PhD on why we coined #ovarianhealth, and our AMH drug program and it's potential in #menopause bit.ly/3CNpuJ2 #WomensHealth #Biotechnology